Popularity of PICCs and concerns about their overuse have increased in recent years.
A VAT was established at a large, tertiary care hospital to meet growing PICC demand.
MC and USGPIV placement was eventually added to the VAT’s capabilities.
VAT-placed MC and USGPIV reduced hospital-wide PICC use.
Purpose: Deep vein thrombosis (DVT) and central line-associated bloodstream infection (CLABSI) are serious complications of peripherally inserted central catheters (PICCs). Because of these risks, midline catheters (MCs) and ultrasound-guided peripheral intravenous catheters (USGPIVs) were added to the capabilities of the host institution’s nursing-based venous access team (VAT), which operates under the direction of Interventional Radiology (IR). This report evaluates this effort to reduce PICCs and MCs through appropriate patient-centered device choice.
Materials: A retrospective analysis of PICCs, MCs, and USGPIVs placed in inpatients in a large tertiary care academic hospital was conducted, using the VAT’s record supplemented with data from the IR quality assurance database. Analysis of hospital records of upper extremity DVT and CLABSI was also performed.
Results: The VAT documented 33,113 PICC, 12,135 MC, and 14,300 USGPIV placements from September 2001 to March 2018. From the peak of PICC placements in 2006 to the peak of MCs in 2010, PICCs decreased 23% (P < 0.01), while MCs increased 93% (P < 0.001). Following full implementation of USGPIV in January 2016, MCs decreased 34% from 2015 to 2016 (P < 0.01) with no concurrent decrease in PICCs (P = 0.72). CLABSI rates per 1000 central venous catheter days decreased from 1.5 to 0.44 (P < 0.01), coinciding with an unrelated CLABSI reduction initiative. No interpretable trends in DVT counts were discovered.
Conclusions: Appropriate use of MCs and USGPIVs by an IR-supported VAT significantly decreased PICCs and MCs, respectively.